Evonile Pharma Schedules Q2 & H1 FY27 Earnings Call for 4th Nov'26
Novartis India Ltd 路 Intimation 路 04 Nov 2026, 2:30 pm
Evonile Pharma Schedules Q2 & H1 FY27 Earnings Call for 4th Nov'26 Evonile Pharma Limited (formerly Novartis India Limited) will host an earnings conference call for investors and analysts on 4th Nov'26 at 2:30 PM IST. The management team, including CFO Bhagwat Singh Deora and President of BD, M&A and IR Jason D'Souza, will discuss the company's unaudited financial results for the quarter and half-year ended 30th Sep'26. Pre-registration is accessible via DiamondPass, alongside universal India dial-ins (+91 22 6280 1488 / +91 22 7115 8869) and international access lines for Hong Kong, Singapore, the UK, and the USA.
Original exchange filing (PDF)
More announcements from Novartis India Ltd
- Transcript of the Earnings Call held on Wednesday, November 04, 2026. 路 06 Nov 2026
- Submission of the Letter of Offer in connection with the proposed Rights Issue of the Partly Paid-up Equity Shares of the Company. 路 06 Nov 2026
- Intimation is hereby given that the record date for determining the rights entitlement for the Rights Issue of partly paid-up shares of the Company shall be Wednesday, November 11, 2026. 路 05 Nov 2026
- Outcome of the Board Meeting held today i.e. November 04, 2026 路 05 Nov 2026
- Outcome of the meeting of the Rights Issue Committee held today i.e. November 04, 2026 路 05 Nov 2026
- Intimation of the Audio Recording of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2026, held today i.e. on Wednesday, November 04, 2026. 路 04 Nov 2026
- Intimation of the Integrated Unaudited Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Press Release - Unaudited Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
